“The biotech/pharma talks were good and the sessions ran to time. The breaks were ideal for networking with attending delegates. The roundtable discussion was really interesting and there was a very diverse group of attendees from different backgrounds and levels taking part.”
Scientific Leader and GSK Associate Fellow, Biopharm Molecular Discovery, GlaxoSmithKline R&D

“The topics covered at the Congress were excellent – there was a good combination of preclinical, biomarkers, clinical and new technologies. The event was well organised and the Oxford Global team were helpful.”
Director of Immuno Monitoring & Biomarker Development, Aduro BioTech

“The event was of a good size with right amount of people attending. There was a good range of talks on both days. The panel discussion was interesting and interactive.”
Scientist I, Adaptimmune Ltd

“The event was very well organised and the choice of venue was good. The talks were interesting and the atmosphere to interact with delegates was great.”
Immunotherapy Scientist, CureVac AG

“The presentations were informative. The opportunity to network with experienced colleagues in the field and to network for potential collaborations. Overall the event was organised well.”
Research Technician, University College London

“The high quality and diversity of the presentations was great. The organisers did a good job.”
Associate Scientist – Lab Head Screening Unit, Agenus Switzerland

“The event had a good mix of delegates making the congress of a good size. The standards of talks were high and the speakers kept to time which was great. Overall, the organisation of the congress was excellent.”
Group Head, University of Oxford

“I liked the venue for the congress and the organisation was excellent. The presentations were of a good standard. Also the opportunity to network with other attendees during breaks was great.”
Senior Scientist, Crescendo Biologics

“The Advances in Immuno-oncology was an excellent event and I really enjoyed speaking with the other attendees. I want to congratulate Oxford Global for their choice of venue and speakers.”
Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, King’s College London

“I really liked that the congress ran to a tight schedule during both days, and that there was a broad range of talks to attend. The Oxford Global staff were of great help.”
Research Associate, UCB

“There was a great focus on close collaboration between biotech/pharma and CROs. There was also ample time for networking opportunities during the breaks and lunch.”
Director Experimental Biomarkers Immuno-oncology, GlaxoSmithKline

“The Advances in Immuno-oncology Congress was a great event that I enjoyed and benefitted from tremendously. I would like to thank all those who were involved.”
Chief Executive Officer, Multimmune GmbH/ Associate Director, and Professor of Immunobiology, John van Geest Cancer Research Centre